AUA 2019: Oncological Effectiveness of Image Guided Thermal Ablation for Recurrent Renal Cell Carcinoma after Ipsilateral Partial Nephrectomy: Tertiary Cancer Center Experience

Chicago, IL ( Renal cell carcinoma is often treated with surgery. Image-guided thermal ablation is a novel technique and surgical alternative that is used to destroy tumors through the application of intense heat.

Dr. Mohamed Abdelsalam and his co-authors sought out to examine image-guided thermal ablation of recurrent renal cell carcinoma (RCC) post-ipsilateral partial nephrectomy, and its oncologic benefits.

The renal ablation database of the institution was utilized throughout the institution within a 13-year time period, in search of patients that had a thermal ablation for recurrent RCC after partial nephrectomy, under certain inclusion criteria (demographics, tumor size, procedure details, complications, etc.).

The study found that out of 46 qualifying cases, 12% of the cohort developed grade III complications according to Clavien-Dino classification, 1 being a urethral injury, 3 patients being a blood clot and ureteral injuries. Abdelsalam presented a case included in the study, that illustrated an initial 1.3cm lesion, it's imaging during biopsy and RFA, and a 9 year follow up displaying no evidence of the lesion.

Abdelsalam concludes his presentation reinstating that image-guided thermal ablation is an effective treatment for recurrent renal cell carcinoma post-ipsilateral partial nephrectomy. He also states that guided and longitudinal imaging shows positive oncologic outcomes.

Presented by: Mohamed E. Abdelsalam, MD, Department of Interventional Radiology, University of Texas MD Anderson Cancer Center

Written by: Aleesa Chavez, (Department of Urology, University of California, Irvine) at the American Urological Association's 2019 Annual Meeting (AUA 2019), May 3 – 6, 2019 in Chicago, Illinois